Kamada KMDA
NASDAQ KMDA
$8.08 +0.19 (+2.41%)
At close: Aug 20, 2026 · 1:46 PM UTC

Kamada (KMDA) EBT Margin (2012 - 2026)

Kamada's (KMDA) quarterly EBT Margin came in at 11.92% in Q1 2026, down 311.0% YoY from 5.65% in Q1 2025, and up 12.46% on a QoQ basis from 10.6% in Q4 2025.

Kamada (KMDA) EBT Margin (2012 - 2026) Analysis & Trends

Kamada (KMDA) has 15 years of EBT Margin data on file, last reported at 11.92% in Q1 2026.

  • Quarterly EBT Margin fell 311.0% year-over-year to 11.92% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.04% (up 1.0% YoY) and the FY2025 annual result came in at 13.0%, up 472.0% from the prior year.
  • EBT Margin advanced to 11.92% in Q1 2026, from 10.6% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 16.77% in Q2 2022 to a low of 0.0% in Q1 2023.
  • A 5-year average of 7.73% and a median of 7.15% in 2022 frame the typical range for EBT Margin.
  • Annual changes were most pronounced in 2022 — EBT Margin jumped 2246 bps — and 2023, when it sank 1168 bps.
  • Tracing KMDA's EBT Margin over 5 years: stood at 7.15% in 2022, then soared by 93 bps to 13.79% in 2023, then slumped by 54 bps to 6.3% in 2024, then jumped by 68 bps to 10.6% in 2025, then advanced by 12 bps to 11.92% in 2026.
  • The last three EBT Margin figures came in at 11.92% (Q1 2026), 10.6% (Q4 2025), and 13.54% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Haleon 43.91 Bn 42.95 Bn - -
2 Teva Pharmaceutical Industries 43.07 Bn 39.42 Bn 2.15 Bn -10.99%
3 Zoetis 31.54 Bn 29.86 Bn 1.05 Bn 35.09%
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn 13.34%
5 United Therapeutics 22.19 Bn 19.53 Bn 683.80 Mn 47.58%
6 Viatris 18.68 Bn 17.79 Bn 1.46 Bn -1.70%
7 Neurocrine Biosciences 15.50 Bn 15.11 Bn 935.80 Mn 16.91%
8 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn 4.09%
9 Dr Reddys Laboratories 10.12 Bn 9.96 Bn - -
10 Kamada 466.36 Mn 436.89 Mn 22.47 Mn 18.55%

Historic Data

Download Data
DateValue
Jun 30, 2026 18.55%
Mar 31, 2026 11.92%
Dec 31, 2025 10.60%
Sep 30, 2025 13.54%
Jun 30, 2025 0.00%
Mar 31, 2025 15.02%
Dec 31, 2024 6.30%
Sep 30, 2024 9.46%
Jun 30, 2024 0.00%
Mar 31, 2024 6.46%
Dec 31, 2023 13.79%
Sep 30, 2023 8.69%
Jun 30, 2023 5.09%
Mar 31, 2023 0.00%
Dec 31, 2022 7.15%
Sep 30, 2022 0.00%
Jun 30, 2022 16.77%
Mar 31, 2022 6.66%
Dec 31, 2021 -15.31%
Sep 30, 2021 3.77%